[July 29, 2016]

Global Lysine Specific Demethylase 1 (LSD-1) Inhibitors Pipeline Insights Report 2016 - Research and Markets

Research and Markets has announced the addition of the "Lysine Specific Demethylase 1 (LSD-1) Inhibitors -Pipeline Insights, 2016" report to their offering.

Lysine Specific Demethylase 1 (LSD-1) Inhibitors-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Lysine Specific Demethylase 1 (LSD-1) Inhibitors.

The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Lysine Specific Demethylase 1 (LSD-1) Inhibitors.

The report also assesses the Lysine Specific Demethylase 1 (LSD-1) Inhibitors therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.

Scope

• The report provides competitive pipeline landscape of Lysine Specific Demethylase 1 (LSD-1) Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Lysine Specific Demethylase 1 (LSD-1) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Lysine Specific Demethylase 1 (LSD-1) Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

1. Overview
2. Pipeline Therapeutics
3. Therapeutics under Development by Companies
4. Filed and Phase III Products
5. Comparative Analysis
6. Phase II Products
7. Comparative Analysis
8. Phase I and IND Filed Products
9. Comparative Analysis
10. Discovery and Pre-Clinical Stage Products
11. Comparative Analysis
12. Drug Candidate Profiles
13. Therapeutics Assessment
14. Assessment by Monotherapy Products
15. Assessment by Combination Products
16. Assessment by Route of Administration
17. Assessment by Molecule Type
18. Discontinued Products
19. Dormant Products
20. Companies Involved in Therapeutics Development

For more information visit http://www.researchandmarkets.com/research/v8h8n8/lysine_specific

View source version on businesswire.com: http://www.businesswire.com/news/home/20160729005654/en/

[ Back To TMCnet.com's Homepage ]